ARCHIVES

Biotherapeutics Reports LAK/IL-2 Toxicity Reduced With Constant Infusion Of IL-2

This article is from The Cancer Letter archive.

Vol. 13 No. 16 | April 17, 1987

Download PDF Visit The Full Archive

Related Articles

NCI Director Among Bush Appointees Asked To Submit Resignation.

December 12, 2008

NCI advisors approve new grants programs. NCI funds consortium of cohorts. Funding opportunities listed.

August 1, 2003

Drug Effectiveness Weakens After Three Years, Study Says

May 27, 2011

FDA Expands Nexavar Indication To Include Thyroid Cancer

December 27, 2013

Fisher Unable To Answer Key Questions, Blames NCI, A Second Hearing On NSABP

June 24, 1994

Proposed FDA Charges For NDA Drugs, Biologics Submissions Would Total $76 Million In FY 1990

January 27, 1989